Hausner L, Steinmetz A, Benson GS, Kalla M, Schönberger A, Schild AK, Fehrenbach S, Knudsen A, Hennig B, Jessen F, Frölich L. [Optimization of the work of outpatient memory clinics from the perspective of value-based healthcare-An approach from the Clinic for Psychiatry and Psychotherapy of the ZI Mannheim]. Nervenarzt. 2026 97(2):171-179. Epub 2025 Nov 20.
Jessen F, Frölich L. [Introduction to the topic: analysis and optimization of the work of outpatient memory clinics]. Nervenarzt. 2026 97(2):161-162.
Martino-Adami P, Jessen F, Brosseron F, Bewernick B, Domschke K, Luppa M, Wagner M, Peters O, Frölich L, Riedel-Heller S, Schramm E, Ramirez A, Dafsari F. Exploring blood-based biomarkers in Late-life Depression: correlates of psychotherapeutic treatment outcomes. Eur Psychiatry. 2026 69(1):e18. Epub 2026 Jan 23.
Merkel J, Perneczky R, Jessen F, Frölich L, Jansen O, Peters S, Berg D, Schulz JB, Bartsch T. Amyloid-related imaging abnormalities (ARIA) in Alzheimer's disease: from pathophysiology to individualized risk assessment. Alzheimers Res Ther. 2026 Mar 28. [Epub ahead of print]
Michel JJ, Sanghvi K, Rosenbauer J, Humbs L, Dierssen CT, Grudzenski-Theis S, Sachs V, Jähne K, Degenhardt K, Frölich L, Herms J, Fatar M, Platten M, Bunse L. Type I interferon drives T cell responses to amyloid beta in the central nervous system. Nat Commun. 2026 17(1)
Perry R, Kipps C, Soto Martín ME, Bozzali M, Logroscino G, Trafford S, Dhadda S, Kanekiyo M, Goodwin A, Hodgkinson M, Hersch S, Irizarry M, Kramer L, Frölich L. Lecanemab for treatment of individuals with early Alzheimer's Disease (AD) who are apolipoprotein E ε4 (ApoE ε4) non-carriers or heterozygotes. J Prev Alzheimers Dis. 2026 13(4):100507. Epub 2026 Feb 13.
Schelter BO, Shiells H, Lo S, Nazlee N, Evans E, Bentham P, Gauthier S, Zetterberg H, Wilcock GK, Frölich L, Burns A, MacSweeney E, Ballard C, Yu JT, Choon TS, Asvatourian V, Muehlemann N, Priel J, Kook K, Sullivan T, Downie D, Miller S, Pringle C, Storey JMD, Baddeley T, Harrington CR, Staff R, Sandu AL, Hull C, Stefanacci R, Wischik CM, Reichl MR. Assessment of clinical and neuroimaging efficacy of treatment targeting tau pathology in mild cognitive impairment and mild to moderate Alzheimer's disease with hydromethylthionine mesylate using external control data. J Prev Alzheimers Dis. 2026 Apr 17. [Epub ahead of print] 13:100560.
Schönberger A, Schild AK, Steinmetz A, Simandi F, Benson GS, Hausner L, Schöttler M, Hennig B, Knudsen A, Maier F, Frölich L, Jessen F. [Optimization of the work of outpatient memory clinics under aspects of value-based healthcare-An approach from the Center for Memory Disorders of the University Hospital Cologne]. Nervenarzt. 2026 97(2):163-170. Epub 2025 Nov 17.
Timsina J, Jiang C, McCartney DL, Tao F, Dalmasso MC, Najar J, Anastasi F, Ohlei O, Puerta Fuentes R, Yang C, Bradley J, Western D, Ali M, Wang C, Yang C, Wu Y, Liu M, Budde J, Williams J, Mahoney R, Castillo Morales A, Hohman TJ, Dumitrescu L, Wang TC, Tesi N, Kern S, Waern M, Skoog I, van Harten A, Pijnenburg YA, van der Flier WM, Sanchez-Juan P, Rodríguez-Rodríguez E, Kleineidam L, Peters O, Schneider A, Küçükali F, Bellenguez C, Grenier-Boley B, Heikkinen S, de Rojas I, Rujescu D, Scherbaum N, Hausner L, Düzel E, Grimmer T, Wiltfang J, Vandenberghe R, Engelborghs S, Heilmann-Heimbach S, Schmid M, Tegos T, Scarmeas N, Dols-Icardo O, Moreno F, Pérez-Tur J, Bullido MJ, Sánchez-Valle R, Alvarez V, García-González P, Mir P, Real LM, Piñol-Ripoll G, García-Alberca JM, Seelaar H, Ramakers I, Papma J, Hulsman M, Laske C, Teipel S, Priller J, Perneczky R, Buerger K, Nöthen MM, Lewczuk P, Kornhuber J, Hampel H, Giegling I, Goldhardt O, Diehl-Schmid J, Andrade V, Heneka MM, Frölich L, Vogelgsang J, Graff C, Thonberg H, Ullgren A, Papenberg G, Deleuze JF, Dufouil C, Wagner M, Jessen F, Holstege H, van Duijn C, Lebouvier T, Hannon O, Leinonen V, Soininen H, Herukka SK, Giedraitis V, Löwenmark M, Kilander L, Genius P, Rodríguez B, Luckett ES, Navarro A, Cano A, Marquié M, Blennow K, Zetterberg H, Lleo A, Boada M, Ruiz A, Lee VM, Van Deerlin VM, Deming Y, Johnson SC, Engelman CD, Pastor P, Alvarez I, Peskind ER, Heslegrave AJ, Saykin AJ, Nho K, Schindler SE, Morris JC, Holtzman DM, McDade E, Renton AE, Goate A, Ibanez L, Riemenschneider M, Albert MS, Laws SM, Porter T, O'Brien EK, Shaw LM, Tijms BM, Ingelsson M, Visser PJ, Hiltunen M, Sleegers K, Ritchie CW, Sims R, Belloy M, Lambert JC, Vilor-Tejedor N, Fernandez MV, Li QS, Nagle MW, Marioni RE, Ramirez A, Bertram L, van der Lee SJ, Cruchaga C. GWAS meta-analysis of cerebrospinal fluid Alzheimer's biomarkers reveals loci regulating lipids, brain volume and autophagy. Nat Commun. 2026 Apr 21. [Epub ahead of print]
Wischik CM, Stefanacci R, Bentham P, Gauthier S, Zetterberg H, Wilcock GK, Frölich L, Burns A, MacSweeney E, Ballard C, Yu JT, Choon TS, Asvatourian V, Muehlemann N, Priel J, Kook K, Sullivan T, Downie D, Miller S, Pringle C, Storey JMD, Baddeley T, Harrington CR, Penny LK, Arastoo M, Staff R, Sandu AL, Shiells H, Lo S, Nazlee N, Evans E, Hull C, Schelter BO. Clinical, imaging and blood biomarker outcomes in a Phase 3 clinical trial of tau aggregation inhibitor hydromethylthionine mesylate in mild cognitive impairment and mild to moderate dementia due to Alzheimer's disease. J Prev Alzheimers Dis. 2026 13(3):100480. Epub 2026 Jan 21.
van der Veere PJ, van Harten AC, van Maurik IS, Teunissen CE, Barkhof F, Vos SJ, Frölich L, Kornhuber J, Wiltfang J, Maier W, Peters O, Rüther E, Frisoni GB, Spiru L, Freund-Levi Y, Wallin AK, Hampel H, Tsolaki M, Kłoszewska I, Mecocci P, Vellas B, Lovestone S, Galluzzi S, Herukka SK, Santana I, Baldeiras I, de Mendonça A, Silva D, Chetelat G, Poisnel G, Visser PJ, Johnson SC, Stormrud E, Hansson O, Palmqvist S, Piñol-Ripoll G, Reichl MR, Berkhof J, van der Flier WM. Revising the ABIDE MCI to dementia prediction model for automated cerebrospinal fluid assays. Alzheimers Dement. 2026 22(2):e71192.